In the market for neurovascular devices, companies continue to innovate and are focusing research and development efforts into novel technologies that could lead to improved outcomes and help fuel growth in the market for ischemic and hemorrhagic stroke devices. At two recent neurointerventional meetings, the Society for NeuroInterventional Surgery (SNIS) 19th Annual meeting and the 14th European Society for Minimally Invasive Neurological Therapy (ESMINT) Congress 2022, SmartTRAK identified emerging technologies that could potentially disrupt the neurovascular market over the next two to five years. This includes enabling technologies for neurointerventional procedures, novel approaches to aspiration for the treatment of acute ischemic stroke (AIS) and innovation in intrasaccular flow disruption devices.
Among the many interesting topics covered in this informative article are: